Open AccessFas ligand expression in colon cancer: A possible mechanism of tumor immune privilege
Author(s) -
Wei Zhang,
Ding Er-xun,
Qiang Wang,
Daqiao Zhu,
Jin He,
Yuli Li,
Yuanhe Wang
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i23.3632
Subject(s) - fas ligand , colorectal cancer , apoptosis , jurkat cells , metastasis , cancer research , cancer , immune system , flow cytometry , immunohistochemistry , immune privilege , biology , pathology , medicine , immunology , t cell , programmed cell death , biochemistry
To detect the expression of Fas ligand (FasL) in colon cancer tissues and cell lines and analyze the function of FasL-expressing colon cancer cells in inducing Fas-sensitive T lymphocyte apoptosis.